Patents Assigned to Prolaio, Inc.
  • Patent number: 12748977
    Abstract: In aspects, the present approaches allow neural networks to be taught to understand patterns of human behavior without the need of expert data labeling or laboratory studies. First and second neural networks are trained to understand these patterns without labeling. Once trained, the neural networks can be deployed with a trained classifier to determine or classify human activity based upon received sensor inputs.
    Type: Grant
    Filed: August 16, 2023
    Date of Patent: September 29, 2026
    Assignee: Prolaio, Inc.
    Inventor: Dylan Richards
  • Patent number: 12670979
    Abstract: An estimate of a functional capacity such as VO2Max is made by applying the vital signs of a monitored human to a trained encoding neural network producing a cardio profile vector. The vector is applied to a trained functional capacity (VO2Max) neural network to estimate the functional capacity. Once estimated, an action is taken.
    Type: Grant
    Filed: April 17, 2024
    Date of Patent: June 30, 2026
    Assignee: Prolaio, Inc.
    Inventor: Dylan Richards
  • Patent number: 12402839
    Abstract: Disclosed herein, in some aspects, are systems and methods for detecting, monitoring, and managing a cardiac health status for a subject using ECG data. In some embodiments, the system receives health parameter measurements from one or more devices that are then used by a cardiac health tool (CHT) to determine a cardiac health status. Exemplary health parameter measurements include electrocardiogram (ECG) data from an ECG device and/or weight (from a weight scale for example). As described herein, in some embodiments, determining the cardiac health status includes a) detecting a cardiac condition in the subject, b) predicting a risk of a subject developing a cardiac condition (“cardiac condition risk”), and/or c) temporal monitoring of a cardiac health status for a subject. In some embodiments, the cardiac health tool is configured to determine the efficacy of a treatment or therapy applied to reduce the severity and/or risk of a cardiac condition.
    Type: Grant
    Filed: July 2, 2024
    Date of Patent: September 2, 2025
    Assignee: Prolaio, Inc.
    Inventors: Jay M. Edelberg, Tassos Gianakakos